High density lipoprotein landmark trials: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) Rim Halaby moved page High density lipoprotein landmark trials to High density lipoprotein complete list of trials |
Rim Halaby (talk | contribs) |
||
| (19 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{High density lipoprotein}} | |||
{{CMG}} | |||
==Reconstituted HDL Infusion== | |||
{| style="font-size:120%" | |||
|- | |||
| [[The CHI SQUARE Trial]] | |||
|- | |||
| [[A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers]] | |||
|- | |||
| [[Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers]] | |||
|- | |||
| [[CSL-112 Trial - Phase 2a]] | |||
|- | |||
| [[ERASE Trial]] | |||
|- | |||
| [[Infusion of Apo A-1 Milano]] | |||
|- | |||
|} | |||
==CETP Inhibitors== | |||
{| style="font-size:120%" | |||
|- | |||
| [[ACCELERATE Trial]] | |||
|- | |||
| [[Dal-OUTCOMES Trial]] | |||
|- | |||
| [[Dal-VESSEL Trial]] | |||
|- | |||
| [[Dal-PLAQUE Trial]] | |||
|- | |||
| [[DEFINE Trial]] | |||
|- | |||
| [[ILLUMINATE Trial]] | |||
|- | |||
| [[ILLUSTRATE Trial]] | |||
|- | |||
| [[REVEAL Trial]] | |||
|- | |||
| [[REVEAL HPS-3 TIMI-55 trial]] | |||
|- | |||
| [[RADIANCE 1]] | |||
|- | |||
| [[RADIANCE 2]] | |||
|- | |||
|} | |||
==Niacin== | |||
{| style="font-size:120%" | |||
|- | |||
| [[AIM-HIGH Trial]] | |||
|- | |||
| [[ARBITER 2 Trial]] | |||
|- | |||
| [[ARBITER 3 Trial]] | |||
|- | |||
| [[ARBITER 6-HALTS Trial]] | |||
|- | |||
| [[CLAS Trial]] | |||
|- | |||
| [[HATS Trial]] | |||
|- | |||
| [[Oxford Niaspan Study]] | |||
|- | |||
| [[Coronary Drug Project]] | |||
|- | |||
| [[Stockholm Ischemic Heart Disease Study]] | |||
|- | |||
| [[FATS]] | |||
|- | |||
| [[UCSF-SCOR]] | |||
|- | |||
|} | |||
==Fibrate== | |||
{| style="font-size:120%" | |||
|- | |||
| [[VA-HIT Trial]] | |||
|- | |||
| [[BECAIT Trial]] | |||
|- | |||
| [[BIP Trial]] | |||
|- | |||
| [[Helsinki Heart Study]] | |||
|- | |||
| [[DAIS]] | |||
|- | |||
| [[FIELD]] | |||
|- | |||
|} | |||
==Statin== | |||
{| style="font-size:120%" | |||
|- | |||
| [[ASTEROID Trial]] | |||
|- | |||
| [[SATURN Trial]] | |||
|- | |||
| [[4S Trial]] | |||
|- | |||
| [[CORONA Trial]] | |||
|- | |||
|} | |||
==Multiple Lipid Lowering Drugs== | |||
{| style="font-size:120%" | |||
|- | |||
| [[HARP Study]] | |||
|- | |||
| [[AFREGS Trial]] | |||
|- | |||
|} | |||
{{Lipopedia}} | |||
[[Category:Lipopedia]] | |||
[[Category:Lipid disorders]] | |||
[[Category:Cardiology]] | |||
[[Category:Lipoproteins]] | |||
[[Category:HDLpedia]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Latest revision as of 02:41, 19 August 2014
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
High density lipoprotein landmark trials On the Web |
|
American Roentgen Ray Society Images of High density lipoprotein landmark trials |
|
Risk calculators and risk factors for High density lipoprotein landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Reconstituted HDL Infusion
CETP Inhibitors
| ACCELERATE Trial |
| Dal-OUTCOMES Trial |
| Dal-VESSEL Trial |
| Dal-PLAQUE Trial |
| DEFINE Trial |
| ILLUMINATE Trial |
| ILLUSTRATE Trial |
| REVEAL Trial |
| REVEAL HPS-3 TIMI-55 trial |
| RADIANCE 1 |
| RADIANCE 2 |
Niacin
| AIM-HIGH Trial |
| ARBITER 2 Trial |
| ARBITER 3 Trial |
| ARBITER 6-HALTS Trial |
| CLAS Trial |
| HATS Trial |
| Oxford Niaspan Study |
| Coronary Drug Project |
| Stockholm Ischemic Heart Disease Study |
| FATS |
| UCSF-SCOR |
Fibrate
| VA-HIT Trial |
| BECAIT Trial |
| BIP Trial |
| Helsinki Heart Study |
| DAIS |
| FIELD |
Statin
| ASTEROID Trial |
| SATURN Trial |
| 4S Trial |
| CORONA Trial |
Multiple Lipid Lowering Drugs
| HARP Study |
| AFREGS Trial |